Cargando…
Can existing unrelated vaccines boost a COVID-19 vaccine prime?
Autores principales: | Hupert, Nathaniel, Marín-Hernández, Daniela, Nixon, Douglas F. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7875710/ https://www.ncbi.nlm.nih.gov/pubmed/33589884 http://dx.doi.org/10.1016/j.eclinm.2021.100758 |
Ejemplares similares
-
Heterologous vaccine interventions: boosting immunity against future pandemics
por: Marín-Hernández, Daniela, et al.
Publicado: (2021) -
Anticipated reduction in COVID-19 mortality due to population-wide BCG vaccination: evidence from Germany
por: Marín-Hernández, Daniela, et al.
Publicado: (2021) -
Heterologous vaccination interventions to reduce pandemic morbidity and mortality: Modeling the US winter 2020 COVID-19 wave
por: Hupert, Nathaniel, et al.
Publicado: (2022) -
Heterologous prime-boost vaccination against COVID-19: is it safe and reliable?
por: Choudhary, Om Prakash, et al.
Publicado: (2021) -
Adopting an heterologous prime-boost strategy in COVID-19 vaccination: the need for locally generated evidence in Africa
por: Oboh, Mary Aigbiremo, et al.
Publicado: (2022)